Category: Guest content

From PhD to Life

This is a guest post from Craig Stropkay. Craig is Director and Life Science Consultant at KOLgroups, LLC Reach for the stars, they said.  You should definitely go get your PhD, you’d be great for it, they said.  Well, I guess they did have a point.  Pursuing my doctorate degree in Molecular Biology at Brandeis was […]


3 Tips for Finding the Right Talent for Your Biotech Startup

This is a guest post from Steve Kirsh. Steve is Founder + Managing Partner of Khameleon Group. When was the last time you used a matchmaking service? Chances are it was today. Platforms like Amazon, Airbnb, eBay and Uber (as well as the proverbial dating sites) have transformed matchmaking into an everyday adventure in which […]


Biotech in Countries Starting with “I” – Part 11: Italy (secondo)

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. The run-up to Christmas in Italy is a magical experience, and a great time to revisit Italian agricultural biotechnology. Readers of this irregular series may recall an earlier entry on […]


Which drug makers do a good job getting poor patients access to their medicines?

The pharmaceutical industry is regularly chastised for failing to do enough to ensure that people in low and middle-income countries have access to its medicines. Yet the real picture is actually more nuanced, according to a newly released report that finds some – but not all – drug makers are making headway. Some companies, for […]


Addressing the Challenges of Pharmaceutical Distribution in International Markets

This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. If domestic pharmaceutical distribution is complex, international distribution is considerably more complicated International growth markets for pharmaceuticals represent enormous opportunities, but they also bring their own unique challenges, including infrastructure, fragmented distribution, and a patchwork […]


Addressing the Challenges of Pharmaceutical Distribution in the United States

This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. Pharmaceutical distributors face significant supply chain challenges Designing, implementing, and managing efficient product distribution can present pharmaceutical distributors and wholesalers with opportunities to create a long term strategic advantage. Distribution of pharmaceuticals has always been […]


Treat pharma as a utility, and 10 other ways states can lower drug prices

As prescription drug costs continue to squeeze state budgets, a group of state health policy makers is offering some novel – and also some familiar – suggestions for coping. These include regulating the pharmaceutical industry as a utility, allowing states to operate as pharmacy benefit managers and waiving some provisions of the Medicaid program. In […]


Process Validation and Its Need in the Biotechnology Industry

This is a guest post from Edward Simpson, a seasoned calibration and technical engineer. Do you have a response to Edward’s post? Respond in the comments section below. Process validation is a crucial component of cGMP (current Good Manufacturing Practice) in industries concerned with public health and safety, such as pharma, bio-pharma and biotech.  What […]


Making sense of drug names

This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. A drug by any other name would work just as well… In William Shakespeare’s play Romeo and Juliet, Juliet uses the phrase “A rose by any other name would smell just as sweet” to argue […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: